Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons

被引:144
作者
McKinley, ET [1 ]
Baranowski, TC [1 ]
Blavo, DO [1 ]
Cato, C [1 ]
Doan, TN [1 ]
Rubinstein, AL [1 ]
机构
[1] Zygogen, Atlanta, GA 30303 USA
来源
MOLECULAR BRAIN RESEARCH | 2005年 / 141卷 / 02期
关键词
zebrafish; MPTP; Parkinson's disease; neurodegeneration; dopamine transporter;
D O I
10.1016/j.molbrainres.2005.08.014
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease is characterized by a severe loss of dopaminergic neurons resulting in a range of motor deficits. The neurotoxin 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP) is known to cause a similar loss of dopaminergic, neurons in the human midbrain with corresponding Parkinsonian symptoms. Several animal species have also shown sensitivity to MPTP, including primates, mice, goldfish, and, most recently, zebrafish. This study demonstrates that the effect of MPTP on dopaminergic neurons in zebrafish larvae is mediated by the same pathways that have been demonstrated in mammalian species. MPTP-induced neurodegeneration was prevented by co-incubation with either the monoamine oxidase-B (MAO-B) inhibitor L-deprenyl or the dopamine transporter (DAT) inhibitor nomifensine. Furthermore, targeted inactivation of the DAT gene by antisense morpholinos also protected neurons from MPTP damage. Thus, the mechanism for MPTP-induced dopaminergic neuron toxicity in mammals is conserved in zebrafish larvae. Effects on swimming behavior and touch response that result from MPTP damage are partially ameliorated by both L-deprenyl and DAT knockdown. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:128 / 137
页数:10
相关论文
共 46 条
[1]   Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine [J].
Anichtchik, OV ;
Kaslin, J ;
Peitsaro, N ;
Scheinin, M ;
Panula, P .
JOURNAL OF NEUROCHEMISTRY, 2004, 88 (02) :443-453
[2]   Chronic systemic pesticide exposure reproduces features of Parkinson's disease [J].
Betarbet, R ;
Sherer, TB ;
MacKenzie, G ;
Garcia-Osuna, M ;
Panov, AV ;
Greenamyre, JT .
NATURE NEUROSCIENCE, 2000, 3 (12) :1301-1306
[3]   Animal models of Parkinson's disease [J].
Betarbet, R ;
Sherer, TB ;
Greenamyre, JT .
BIOESSAYS, 2002, 24 (04) :308-318
[4]   Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter [J].
Bezard, E ;
Gross, CE ;
Fournier, MC ;
Dovero, S ;
Bloch, B ;
Jaber, M .
EXPERIMENTAL NEUROLOGY, 1999, 155 (02) :268-273
[5]   Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease [J].
Blum, D ;
Torch, S ;
Lambeng, N ;
Nissou, MF ;
Benabid, AL ;
Sadoul, R ;
Verna, JM .
PROGRESS IN NEUROBIOLOGY, 2001, 65 (02) :135-172
[6]   Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease [J].
Bretaud, S ;
Lee, S ;
Guo, S .
NEUROTOXICOLOGY AND TERATOLOGY, 2004, 26 (06) :857-864
[7]   METABOLISM OF THE NEUROTOXIC TERTIARY AMINE, MPTP, BY BRAIN MONOAMINE-OXIDASE [J].
CHIBA, K ;
TREVOR, A ;
CASTAGNOLI, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) :574-578
[8]   Neuroprotective actions of selegiline [J].
Ebadi, M ;
Sharma, S ;
Shavali, S ;
El Refaey, H .
JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 67 (03) :285-289
[9]   Species differences in the role of excitatory amino acids in experimental parkinsonism [J].
Fornai, F ;
Vaglini, F ;
Maggio, R ;
Bonuccelli, U ;
Corsini, GU .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (04) :401-415
[10]  
Gainetdinov RR, 1997, J NEUROCHEM, V69, P1322